Apr. 5, 2023
J&J agrees to pay $8.9 billion to settle talc cases
“The company continues to believe that these claims are specious and lack scientific merit,” said Erik Haas, Johnson & Johnson’s worldwide vice president of litigation. “However, as the bankruptcy court recognized, resolving these cases in the tort system would take decades and impose significant costs on LTL and the system, with most claimants never receiving any compensation.”
Johnson & Johnson agreed Tuesday to pay at least $8.9 billion over 25 years to thousands of current and future plaintiffs who say its talc powder products cause gynecologic cancers or mesothelioma.
“After nearly a decade of litigation, this long-awaited settlement finally secures closure for our clients and their families. This is a victory for the women of California and for women all across the country,” said Melanie Palmer of Kiesel ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In